Observational studyScientific reports2026
T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injury.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with traumatic spinal cord injury (SCI) frequently develop urinary tract infections (UTI) which may compromise neurological rehabilitation. We explored risk factors for UTI, including immunological biomarkers, in patients with acute traumatic SCI during the transition from acute to subacute phase. Two observational studies were analysed separately: a retrospective study (COaT-SCI, n = 296, follow-up 13 weeks), and a prospective immunological study (SCIentinel, n = 70, follow-up 10 weeks). Cox regression models were used to examine associations of first UTI with patient characteristics and longitudinal immunological parameters. Cumulative incidence of first UTI was approximately 50% at six weeks. Results indicated higher UTI risk in older patients and time-varying associations for SCI severity (ASIA impairment scale) and presence of accompanying injuries. Higher cellular immune competence, particularly CD8 + T-cell counts and higher IFN-γ/IL-4 ratio in functional T-cell assays, were associated with a lower UTI risk (HR [95% CI] per log-transformed unit: CD8 + T-cells 0.34 [0.18-0.65], IFN-γ/IL-4 ratio 0.53 [0.33-0.83]). Adding cellular immune markers improved models' discriminative ability (weighted C-index at 21 days from 0.68 to 0.76 with CD8 + T-cells). These findings indicate UTI is facilitated by systemic immune alterations, with T-cell parameters representing promising predictive biomarkers requiring further validation before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.